Cargando…
Statins and other drugs: Facing COVID-19 as a vascular disease
Autores principales: | Sanchis-Gomar, Fabian, Perez-Quilis, Carme, Favaloro, Emmanuel J., Lippi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834489/ https://www.ncbi.nlm.nih.gov/pubmed/32562814 http://dx.doi.org/10.1016/j.phrs.2020.105033 |
Ejemplares similares
-
In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020) -
Estimating the burden of mental health impairment after COVID-19
por: Mattiuzzi, Camilla, et al.
Publicado: (2022) -
Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress
por: Lippi, Giuseppe, et al.
Publicado: (2021) -
Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing
por: Lippi, Giuseppe, et al.
Publicado: (2020) -
In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)